The review Advances in Genome Editing Through Haploid Induction Systems (Int J Mol Sci 2025) synthesizes recent advances linking haploid induction genes (MTL/NLD/ZmPLA1, DMP, CENH3, ZmPOD65, ZmPLD3), HI-Edit/IMGE strategies, and direct editing of gametes/haploids; it is comprehensive and practically useful but limited by uneven crossspecies validation, variable HIRs, and reliance on published positive results
The review integrates genetic, biochemical, and applied breeding literature to describe how haploid induction (HI) genes and systems have been discovered and repurposed with genome editing to accelerate doubled haploid (DH) breeding and enable transgene free genome editing (HI-Edit, IMGE). It covers: (1) major HI loci and proposed mechanisms (MTL/NLD/ZmPLA1 phospholipase pathway; DMP family; CENH3 centromere mediated elimination; ZmPOD65, ZmPLD3); (2) CRISPR/TALEN/ZFN-based creation of in vivo HI lines across maize rice wheat barley sugarcane and several dicots; (3) HI-Edit and IMGE pipeline logic and outcomes; (4) limitations and future directions, including low HIR for many crops and the need for nontransgenic delivery and spontaneous doubling strategies
These follow logically from the review synthesis and the review authors explicit future perspectives
Notes: HIR points taken from review tabulated summaries and case studies; values are representative maxima or averages reported by primary studies compiled by the review (see review for references and details)
The review is a high quality, timely synthesis that will be valuable to molecular breeders and plant geneticists because it assembles mechanistic hypotheses, gene targets, and applied HI-Edit/IMGE pipelines into a single actionable narrative. However, implementing these strategies at breeding scale will require systematic crossspecies validation, transparent reporting of negative results, improved nontransgenic delivery methods, and operational genomic QC to manage off target and aneuploidy risks β gaps that the review notes but cannot itself fill because it is not primary research
Know what changed, what holds up, and what remains uncertain. Every Friday. No ads.